209 related articles for article (PubMed ID: 28270148)
1. MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability.
Mancini F; Teveroni E; Di Conza G; Monteleone V; Arisi I; Pellegrino M; Buttarelli M; Pieroni L; D'Onofrio M; Urbani A; Pontecorvi A; Mazzone M; Moretti F
Mol Cancer; 2017 Mar; 16(1):55. PubMed ID: 28270148
[TBL] [Abstract][Full Text] [Related]
2. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage.
Cam M; Bid HK; Xiao L; Zambetti GP; Houghton PJ; Cam H
J Biol Chem; 2014 Feb; 289(7):4083-94. PubMed ID: 24366874
[TBL] [Abstract][Full Text] [Related]
3. GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling.
Stretton C; Hoffmann TM; Munson MJ; Prescott A; Taylor PM; Ganley IG; Hundal HS
Biochem J; 2015 Sep; 470(2):207-21. PubMed ID: 26348909
[TBL] [Abstract][Full Text] [Related]
4. [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
Longerich T
Pathologe; 2014 Nov; 35 Suppl 2():177-84. PubMed ID: 25394965
[TBL] [Abstract][Full Text] [Related]
5. The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.
Bermudez-Silva FJ; Romero-Zerbo SY; Haissaguerre M; Ruz-Maldonado I; Lhamyani S; El Bekay R; Tabarin A; Marsicano G; Cota D
Dis Model Mech; 2016 Jan; 9(1):51-61. PubMed ID: 26563389
[TBL] [Abstract][Full Text] [Related]
6. Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism.
Schriever SC; Deutsch MJ; Adamski J; Roscher AA; Ensenauer R
J Nutr Biochem; 2013 May; 24(5):824-31. PubMed ID: 22898570
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
[TBL] [Abstract][Full Text] [Related]
8. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
9. Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model.
Lamming DW; Cummings NE; Rastelli AL; Gao F; Cava E; Bertozzi B; Spelta F; Pili R; Fontana L
Oncotarget; 2015 Oct; 6(31):31233-40. PubMed ID: 26378060
[TBL] [Abstract][Full Text] [Related]
10. The expanding role of mTOR in cancer cell growth and proliferation.
Cargnello M; Tcherkezian J; Roux PP
Mutagenesis; 2015 Mar; 30(2):169-76. PubMed ID: 25688110
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.
Gao S; Duan C; Gao G; Wang X; Yang H
Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876
[TBL] [Abstract][Full Text] [Related]
12. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
13. EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.
Pellegrino R; Calvisi DF; Neumann O; Kolluru V; Wesely J; Chen X; Wang C; Wuestefeld T; Ladu S; Elgohary N; Bermejo JL; Radlwimmer B; Zörnig M; Zender L; Dombrowski F; Evert M; Schirmacher P; Longerich T
Hepatology; 2014 May; 59(5):1886-99. PubMed ID: 24285179
[TBL] [Abstract][Full Text] [Related]
14. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S
Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619
[TBL] [Abstract][Full Text] [Related]
15. Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.
Iwata TN; Ramírez JA; Tsang M; Park H; Margineantu DH; Hockenbery DM; Iritani BM
J Immunol; 2016 Sep; 197(6):2250-60. PubMed ID: 27521345
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.
Nagamori S; Wiriyasermkul P; Okuda S; Kojima N; Hari Y; Kiyonaka S; Mori Y; Tominaga H; Ohgaki R; Kanai Y
Amino Acids; 2016 Apr; 48(4):1045-1058. PubMed ID: 26724922
[TBL] [Abstract][Full Text] [Related]
17. Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing of anagen entry in mouse hair follicles.
Kellenberger AJ; Tauchi M
Exp Dermatol; 2013 Jan; 22(1):77-80. PubMed ID: 23278901
[TBL] [Abstract][Full Text] [Related]
18. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.
Ruf S; Heberle AM; Langelaar-Makkinje M; Gelino S; Wilkinson D; Gerbeth C; Schwarz JJ; Holzwarth B; Warscheid B; Meisinger C; van Vugt MA; Baumeister R; Hansen M; Thedieck K
Autophagy; 2017 Mar; 13(3):486-505. PubMed ID: 28102733
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 signaling and the metabolic control of cell growth.
Ben-Sahra I; Manning BD
Curr Opin Cell Biol; 2017 Apr; 45():72-82. PubMed ID: 28411448
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.
Leung EY; Askarian-Amiri M; Finlay GJ; Rewcastle GW; Baguley BC
PLoS One; 2015; 10(7):e0131400. PubMed ID: 26148118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
